Global Cough Syrup Market is expected to Advance at a CAGR of 3.27% by 2028
Triton Market Research presents the Global Cough Syrup Market segmented by Product Type (Cough Suppressants/Antitussives, Combination Medications, Expectorants), Age Group (Adult, Pediatric), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Geography (North America, Latin America, Middle East and Africa, Europe, and Asia-Pacific).
It further discusses the Market Summary,
Industry Outlook, Impact of COVID-19, Key Insights, Porter’s Five Forces Model,
Market Attractiveness Index, Vendor Scorecard, Key Market Strategies, Drivers,
Challenges, Opportunities, Competitive Landscape, Research Methodology &
Scope, Global Market Size, Forecasts & Analysis (2022-2028).
Triton Market Research’s report states
that the global cough syrup market would expand with a 3.27% CAGR during the
forecasted years from 2022 to 2028.
Request free sample:
https://www.tritonmarketresearch.com/reports/cough-syrup-market#request-free-sample
The significant rise in air pollution,
smoking, and climate change has raised the risk of respiratory ailments. People
suffer from various respiratory problems such as asthma, lung cancer, chronic
lung infection, chronic obstructive pulmonary disease, etc., that block the
airways, thus making it difficult to breathe. To solve these issues, cough
syrups are commonly used to provide relief as it reduces and loosens the mucus
present in the airways, thereby eliminating congestion. Moreover, the geriatric
population suffers from respiratory failures due to aging, which raises the
demand for cough syrups.
However, over-consumption and misuse of
cough syrups have become a teen drug addiction problem. Also, several
governments have banned the production and importation of cough syrup
containing codeine which hampers the studied market’s growth process.
Globally, the Asia-Pacific is leading the
market and is expected to continue its stronghold in the forecast years. The
growth is supported by the prevalence of asthma and increased air pollution
& greenhouse farming that causes respiratory disorders among the
population. Besides, countries like Japan, South Korea, Thailand, etc., are
vulnerable to respiratory diseases owing to the rising geriatric population.
These factors are expected to fuel the cough syrup market in the Asia-Pacific
region.
The prominent players in the global cough
syrup market include Proctor and Gamble Co, Merck KGAA, Pfizer Inc, Johnson and
Johnson, Glaxosmithkline, Acella Pharmaceuticals LLC, Novartis International
AG, Sanofi SA, Reckitt Benckiser Group Plc, Cipla Limited, The Himalaya Drug
Company, Dabur India Ltd, AstraZeneca Plc, Glenmark Pharmaceuticals Limited,
and Abbott Laboratories.
There is stringent competitive rivalry
among the market players in producing cough syrups. Companies invest heavily in
R&D and spend millions on expanding their facilities which intensifies the
competition. Also, they produce innovative and more effective products that
boost their product portfolio. Additionally, the threat of new entrants in the
market is quite low due to the presence of dominating players such as Proctor
and Gamble Co, Johnson and Johnson, etc.
Contact
Us:
sales@tritonmarketresearch.com
Phone: +44 7441 911839

Comments
Post a Comment